Jun 01, 2018 - Barclays issues rating change for GRFS
May 31, 2018 - Grifols S.A. (NASDAQ:GRFS) had declared $0.250975/share semi-annual dividend.Payable June 5; for shareholders of record May 31; ex-div June 1.
May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
May 22, 2018 - Payments processor serving the niche plasma donation market. Share winner in a growing industry with revenue potentially 4-8x higher in four years.Strong financial profile with high margins, ROIC, and
May 09, 2018 - Engadine Partners LLP Buys Grifols SA, Monster Beverage Corp, Sells GCP Applied Technologies Inc, Coca-Cola European Partners PLC, Stocks: GRFS,MNST,GCP,CCE,, release date:May 09, 2018
Apr 10, 2018 - Sales and earnings growth have been tremendous.Profit margins were over 15% last year.The annual report was just released.The stock may be down on worries with China trade.
Mar 12, 2018 - Aradigm and Grifols try for European approval.Pfizer's GI advisory committee goes rather smoothly.VBL Therapeutics fails on glioblastoma treatment.
Mar 06, 2018 - ADMA’s lead product candidate has generated very positive clinical data, and is positioned to meet a very high unmet medical need.ADMA has acquired a specialised hyper-immune fractionation facility, w
Mar 06, 2018 - We expect Henry Schien's (HSIC) partnership with Grifols to be strategically accretive to its portfolio given the rising demand for saline products in U.S. market.
Feb 02, 2018 - The CRL was a setback.Some considerations for investors are posed here.EMA?